Aigen Investment Management LP Acquires Shares of 4,416 Azenta, Inc. (NASDAQ:AZTA)

Aigen Investment Management LP bought a new position in shares of Azenta, Inc. (NASDAQ:AZTA) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,416 shares of the company’s stock, valued at approximately $214,000.

Several other institutional investors have also recently made changes to their positions in the business. Hantz Financial Services Inc. acquired a new stake in Azenta during the 2nd quarter worth about $30,000. Farther Finance Advisors LLC grew its holdings in Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after acquiring an additional 256 shares during the period. Benjamin F. Edwards & Company Inc. raised its position in Azenta by 150.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after acquiring an additional 955 shares in the last quarter. Lazard Asset Management LLC acquired a new position in Azenta in the first quarter valued at approximately $130,000. Finally, Acadian Asset Management LLC boosted its position in Azenta by 24.7% in the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after purchasing an additional 471 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Herman Cueto sold 1,595 shares of Azenta stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total value of $69,669.60. Following the sale, the chief financial officer now directly owns 24,604 shares of the company’s stock, valued at $1,074,702.72. The trade was a 6.09 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.77% of the stock is owned by company insiders.

Azenta Stock Performance

Azenta stock opened at $41.51 on Friday. The stock has a market capitalization of $2.03 billion, a P/E ratio of -13.98 and a beta of 1.48. The company’s fifty day moving average price is $45.56 and its 200 day moving average price is $50.44. Azenta, Inc. has a 1 year low of $40.24 and a 1 year high of $69.16.

Azenta (NASDAQ:AZTA) last announced its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.08. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business had revenue of $170.00 million for the quarter, compared to analyst estimates of $169.66 million. During the same quarter last year, the business earned $0.13 earnings per share. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. Sell-side analysts predict that Azenta, Inc. will post 0.42 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on AZTA. Evercore ISI cut their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Needham & Company LLC cut their price objective on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $63.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.